News & insights

Search all news & insights

    Latest news

    Show
    news from

    Autolus Therapeutics Presents Clinical Data Updates at the American College of Rheumatology Convergence 2025

    Mosaic Therapeutics appoints Thomas Fuchs as CEO

    Autolus Therapeutics Announces First Patient Dosed in Phase 1 Trial of Obecabtagene Autoleucel (Obe-Cel) in Patients with Progressive Multiple Sclerosis

    iOnctura debuts cambritaxestat (IOA-289) clinical data in patients with pancreatic cancer at ESMO

    Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025

    Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress

    View all news

    Latest insights & articles

    Show
    insights & articles from

    A new partner: Horatio’s Garden

    Supporting UK life science

    Market Review: Fundamentals are robust, despite uncertainty

    Fellowship Spotlight Series: Ellis Kelly

    Introducing Slingshot Therapeutics

    Creating Yellowstone – Syncona’s launch team in action

    View all insights & articles

    Latest publications & presentations

    Show presentations from

    Spur Corporate Presentation - February 2025

    Download PDF (2.75Mb)

    Autolus Corporate Presentation - January 2025

    Download PDF (2.38Mb)

    Syncona - Half Year 2024 Presentation

    Download PDF (3.42Mb)

    Syncona Investor Webinar: Beacon Therapeutics

    Download PDF (1.64Mb)

    Spur Corporate Presentation - October 2024

    Download PDF (1.81Mb)

    Autolus Corporate Presentation - September 2024

    Download PDF (1.71Mb)
    View all publications & presentations

    Search